Role functioning in Robotic assisted versus laparoscopic liver resectio

Not Applicable

• Conditions: C22; C78.7; Malignant neoplasm of liver and intrahepatic bile ducts; Secondary malignant neoplasm of liver and intrahepatic bile duct

• Registration Number: DRKS00027531
• Lead Sponsor: niversitätsklinikum Mannheim

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-02-04
• Study Completion: 2023-12-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 81

Inclusion Criteria

1. Age equal to or greater than 18 years
2. Curative-intent minimally invasive (robotic-assisted or laparoscopic) liver surgery for confirmed or suspected primary or secondary malignancies
3. Written informed consent
4. Ability and willingness to respond questionnaires

Exclusion Criteria

1. ASA = 4
2. Impaired mental state or incompetence of understanding the German language (no fluent German language speaker)
3. Expected lack of compliance

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes of quality of life measures within 90 days after surgery using the EORTC QLQ-C30 questionnaire role functioning item (at postoperative day 30, 60, and 90)

Secondary Outcome Measures

Name	Time	Method
Operating time, Blood loss, Postoperative morbidity and mortality, Conversion rate to open surgery, time-to-functional recovery, Pathological Characteristics, Costs